<--- Back to Details
First PageDocument Content
Blood / Coagulation system / Anatomy / CSL Behring / Von Willebrand disease / Factor VIII / Coagulation / CSL Limited / Hereditary angioedema / Haemophilia / Factor IX / Factor VII
Date: 2013-11-18 05:52:30
Blood
Coagulation system
Anatomy
CSL Behring
Von Willebrand disease
Factor VIII
Coagulation
CSL Limited
Hereditary angioedema
Haemophilia
Factor IX
Factor VII

News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

Add to Reading List

Source URL: www.cslbehring.at

Download Document from Source Website

File Size: 82,62 KB

Share Document on Facebook

Similar Documents

CSL Behring AG WankdorfstrasseBern 22 Switzerland  sitem-insel AG

CSL Behring AG WankdorfstrasseBern 22 Switzerland sitem-insel AG

DocID: 1uREs - View Document

News Releases  Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

DocID: 1sx8q - View Document

Uwe E. Jocham Direktionspräsident CSL Behring Recombinant Facility AG, Lengnau/Schweiz Uwe E. Jocham, geboren in Frankfurt, Deutschland, studierte Pharmazie an der LudwigMaximilians-Universität (LMU) in München. Nach

Uwe E. Jocham Direktionspräsident CSL Behring Recombinant Facility AG, Lengnau/Schweiz Uwe E. Jocham, geboren in Frankfurt, Deutschland, studierte Pharmazie an der LudwigMaximilians-Universität (LMU) in München. Nach

DocID: 1sesH - View Document

MAJOR THERAPEUTIC PRODUCTS MARKETED by CSL Behring Hematology Specialty Care

MAJOR THERAPEUTIC PRODUCTS MARKETED by CSL Behring Hematology Specialty Care

DocID: 1sb17 - View Document

[Product Monograph Template - Schedule D]

[Product Monograph Template - Schedule D]

DocID: 1rjWd - View Document